← All stocks

BIOVIE INC.

BIVI Net buying
CIK 0001580149 #5165 in the set updated 17 Sep 2026
Bought (120 mo)
$513.14K
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$352.70K
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$352.70K
8 of 8 sales
Net
+$160.43K
+$160.43K against sales at will

By person

18 insiders · 28 transactions
20.9×

Cuong Do holds 20.9 times base salary in stock. $12.94M of shares against $618.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Cuong Do last reported holding, valued at $2.18, the price Common Stock was last bought or sold at on the open market here, on 28 Aug 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
GORLIN STEVE
Director
$435.42K (11)
$154.01K (2)
+$281.41K
111,558
$243.20K
+59.1%
BERMAN RICHARD J
Director
$198.70K (6)
−$198.70K
40,643
$88.60K
DO CUONG V
President & CEO
$49.44K (4)
+$49.44K
5,935,484
$12.94M
+22.7%
KIM JOANNE WENDY
Chief Financial Officer
$16.25K (2)
+$16.25K
5,441
$11.86K
Palumbo Joseph M
Chief Medical Officer
$10.46K (1)
+$10.46K
6,036
$13.16K
Chappell Amy Suzon
Director
$1.57K (1)
+$1.57K
727
$1.58K
PEIZER TERREN S
Director
27,425,166
$59.79M
+543.9%
Sooch Mina
Director
813,636
$1.77M
+208.6%
Kumar Hari
Director
727,272
$1.59M
+433.3%
Sherman Michael Edward
Director
718,181
$1.57M
+1,294%
Anderson Julie G
Director
368,500
$803.33K
+268.5%
Lang James Paul
Director
68,622
$149.60K
Adams Jonathan M
EVP Liver Cirrhosis Programs
48,630
$106.01K
MARKHAM PENELOPE
EVP Liver Cirrhosis R&D
47,841
$104.29K
+347.4%
Hariri Robert J
Director
42,254
$92.11K
Ahlem Clarence N.
EVP Neuroscience Product Dev.
37,148
$80.98K
READING CHRISTOPHER
EVP Neuroscience R&D
37,148
$80.98K
ROGICH SIGMUND
Director
36,926
$80.50K

No percentages here. This company's share count has moved by a factor of 2.5 over the window, from 7,540,316 to 18,562,376 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
KIM JOANNE WENDY
28 Aug 2026
Chief Financial Officer
Buy
2,500
$2.18
$5.45K
Chappell Amy Suzon
28 Aug 2026
Director
Buy
727
$2.16
$1.57K
Palumbo Joseph M
28 Aug 2026
Chief Medical Officer
Buy
4,843
$2.16
$10.46K
DO CUONG V
27 Aug 2026
President & CEO
Buy
15,210
$2.08
$31.64K
DO CUONG V
7 Aug 2025
President & CEO
Buy indirect
5,000
no price
DO CUONG V
4 Mar 2024
President & CEO
Buy indirect
10,000
no price
GORLIN STEVE
1 Dec 2023
Director
Sell
75,680
$1.69
$127.90K
DO CUONG V
30 Nov 2023
President & CEO
Buy
10,000
$1.78
$17.80K
GORLIN STEVE
5 Sep 2023
Director
Sell
8,560
$3.05
$26.11K
BERMAN RICHARD J
22 Aug 2023
Director
Sell
10,805
$3.50
$37.83K
BERMAN RICHARD J
7 Jun 2023
Director
Sell
5,984
$5.81
$34.78K
BERMAN RICHARD J
22 May 2023
Director
Sell
5,000
$6.50
$32.51K
BERMAN RICHARD J
28 Mar 2023
Director
Sell
2,613
$8.52
$22.26K
BERMAN RICHARD J
28 Mar 2023
Director
Sell
5,000
$8.52
$42.61K
BERMAN RICHARD J
27 Mar 2023
Director
Sell
3,371
$8.52
$28.71K
KIM JOANNE WENDY
7 Dec 2021
CFO
Buy
2,000
$5.40
$10.80K
GORLIN STEVE
3 Nov 2020
Director
Buy
2,430
$7.95
$19.32K
GORLIN STEVE
30 Oct 2020
Director
Buy
2,570
$7.97
$20.48K
GORLIN STEVE
21 Oct 2020
Director
Buy
5,000
$9.19
$45.95K
GORLIN STEVE
15 Oct 2020
Director
Buy indirect
100
$10.27
$1.03K
GORLIN STEVE
15 Oct 2020
Director
Buy indirect
1,000
$10.18
$10.18K
GORLIN STEVE
15 Oct 2020
Director
Buy indirect
4,000
$10.19
$40.76K
GORLIN STEVE
15 Oct 2020
Director
Buy
5,000
$10.10
$50.50K
GORLIN STEVE
15 Oct 2020
Director
Buy
5,000
$10.01
$50.05K
GORLIN STEVE
9 Oct 2020
Director
Buy
282
$9.61
$2.71K
GORLIN STEVE
7 Oct 2020
Director
Buy
4,718
$9.42
$44.44K
GORLIN STEVE
22 Sep 2020
Director
Buy
15,000
$10.00
$150.00K
PEIZER TERREN S
22 Sep 2020
Director
Exercised, kept indirect
1,549,750
$0.00
$154.98

What was left out

Form 4 filings counted 113
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 8
Transactions with no price 2
Shares from compensation/vesting 28,447,683
History held since 1 Aug 2018